SEC Form 4 · accession 0001104659-16-090797
PLx Pharma Inc. · PLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Deluccia
Officer — Executive Chairman · Director · 10% Owner
Period of report
Jan 19, 2016
Accepted (ET)
Jan 21, 2016 · 3:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $10.16 | Jan 19, 2016 | A | 35,000 | A | — | Jan 19, 2026 | Common stock, $0.001 par value per share | 35,000 | 35,000 | D |
Explanation of responses
- F1Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period.